Reneo Pharmaceuticals, Inc.·4

Dec 13, 6:13 PM ET

Lam Jennifer 4

4 · Reneo Pharmaceuticals, Inc. · Filed Dec 13, 2022

Insider Transaction Report

Form 4
Period: 2022-12-09
Lam Jennifer
VP of Finance & Administration
Transactions
  • Award

    Stock option (right to buy)

    2022-12-09+90,00090,000 total
    Exercise: $1.80Exp: 2032-12-08Common Stock (90,000 underlying)
Holdings
  • Common Stock

    20,600
Footnotes (2)
  • [F1]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on June 8, 2022 and 4,000 shares acquired under the Plan on December 8, 2022.
  • [F2]The shares vest in a series of equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION